
Avantor Inc. (AVTR) Stock Forecast & Price Target
Avantor Inc. (AVTR) Analyst Ratings
Bulls say
Avantor is a global provider of products and services to the biopharma, healthcare, education, and advanced technologies industries. Their diverse product offerings include high-purity chemicals, lab supplies, customized excipients, and single-use assemblies. The company has recently seen a turnaround in their performance, with their laboratory solutions segment reporting its first positive quarter in several periods due to revitalization efforts and improving pharma/biotech activity. The bioscience production segment is expected to return to positive organic growth in the near future. While the company is currently facing headwinds from large customer losses, they are taking steps to address these concerns and have shown early signs of improvement. With a global footprint and a strong portfolio of products, Avantor has the potential to benefit from an improved market outlook and potential share gains. Their focus on sustainability and responsible sourcing also positions them well for long-term value creation. Based on their expected performance and current industry trends, I have a positive outlook on Avantor's stock.
Bears say
Avantor is a leading provider of products and services to the biopharma, healthcare, education and government, and advanced technologies industries. Despite recent signs of end market recovery, the company still faces challenges from strong competition and a potential shift towards dry lab work in the future. With a projected lower growth rate compared to its competitors, Avantor's current valuation may be justified. However, if the company is able to outperform expectations and see faster growth, there is potential for an upside in its stock price.
This aggregate rating is based on analysts' research of Avantor Inc. and is not a guaranteed prediction by Public.com or investment advice.
Avantor Inc. (AVTR) Analyst Forecast & Price Prediction
Start investing in Avantor Inc. (AVTR)
Order type
Buy in
Order amount
Est. shares
0 shares